Described herein are pharmaceutical packaging systems which prevent oxidative degradation of morphine, hydromorphone, promethazine as well as other oxygen-sensitive medicine, this kind of systems which includes a syringe using an oxygen permeable idea cap, a hermetically sealed oxygen barrier blister packaging with quite reduced permeability to oxy